Researchers have adapted CAR-T therapy, used in cancer treatment, to combat HIV, achieving promising results in two patients. They received a single dose of genetically modified T cells, which suppressed the virus for nearly one year and two years, respectively, without the need for regular medications. Dr. Steven Deeks, the study leader from the University of California, emphasized the need for a safe and effective solution for HIV. Although CAR-T therapy has shown promising results, larger studies are needed to confirm its long-term efficacy. Nearly 40 million people live with HIV worldwide, and current treatments are costly and require constant adherence. The new approach involves creating CAR-T cells capable of identifying and destroying HIV-infected cells, offering new hope in the search for a possible cure. Although the results are encouraging, experts warn that further research is needed to validate these findings.
Sources
Small study hints that revving up immune cells might help fight HIV
Un studiu recent arată că o singură sesiune de terapie celulară poate ține sub control infecția cu HIV
Studiu: O singură sesiune de terapie celulară poate ţine sub control infecţia cu HIV. Cum acționează
Latest News
16:04
An Irishman is accused of destroying a U.S. C-130 military aircraft in a planned attack at Shannon Airport
15:36
Why Google’s Android Earthquake Alerts system displayed a higher magnitude than INFP for the earthquake in Romania – Explanations from the Institute for Earth Physics
15:24
Nicușor Dan will attend the Coalition of the Willing meeting in Berlin, ahead of new negotiations for peace in Ukraine
15:08
Russian services allegedly planned a “false flag” operation in Poland
14:50
Bloomberg: Russia reportedly proposed NATO return to its 1997 borders in exchange for the withdrawal of troops from Kaliningrad
See more news